Meningococcal Vaccines Market Business Prospect Forecast To 2027
Precision Business Insights published a research report on " Global Meningococcal Vaccines Market by Type (Meningococcal Conjugate Vaccines, Meningococcal Polysaccharide Vaccine, Serogroup B Meningococcal Vaccine), By End user (Hospitals, Clinic, Others), and By Geography- Global/Region/Country Forecast to 2027". The global meningococcal vaccines market was valued USD 3.2 billion in the year 2020 and anticipated to value at USD 5.81 billion till 2027 witnessing a CAGR rate of 8.9% during the forecast period 2021-2027. Meningococcal disease is a fatal disease caused due to bacteria named Neisseria Meningitides. It causes possible infection in the meninges, the thin layers of connective tissues that enclose brain and spinal cord. A few of the common symptoms of this disease are pneumonia, bacteraemia and meningitis related with high fever, vomiting, rashes, nausea, lethargy and stiffness. Moreover, growing R&D investments by different key players, increasing con